Objective:Small cell lung carcinoma(SCLC)is considered one of the most aggressive types of lung cancer due to its rapid growth and early metastasis.No tumor markers or therapeutic targets have been demonstrated to be ...Objective:Small cell lung carcinoma(SCLC)is considered one of the most aggressive types of lung cancer due to its rapid growth and early metastasis.No tumor markers or therapeutic targets have been demonstrated to be specific or effective in SCLC to date.This study aims to evaluate the potential of Flotillin1(Flot1)as a target of SCLC treatment.Methods:Flot1 expression level in the tissue of SCLC and other tissue of lung disease was detected using immunohistochemical staining.Transwell and Matrigel assays were employed to examine migration and invasion of cancer cells.Flow cytometry and xCELLigence system were used to evaluate cell apoptosis and cell viability,respectively.Expression levels of Flot1,epithelialmesenchymal transition(EMT)marker E-cadherin,vimentin,cyclinD1,TGF-β-Smad2/3,and p-AKT were examined using Western blot.Furthermore,xenograft tumor in nude mice was used to evaluate the growth and metastasis of NCI-H446 cells in vivo.Results:Our results demonstrated that Flot1 is highly expressed in SCLC samples and that its expression correlates strongly with clinical stage,distant metastasis,and poor survival.The knockdown of Flot1 decreased the growth,migration,and invasiveness of SCLC cells and reversed EMT phenotype in vitro and in vivo,while enhanced Flot1 expression exhibited the opposite behavior.Gene expression profile analysis demonstrated that Flot1-regulated genes frequently mapped to the AKT and TGF-β-Smad2/3pathways.Our results further revealed that Flot1 affected the progression of SCLC via regulation of EMT progression.Conclusions:These findings indicated an oncogenic role of Flot1 via promoting EMT in SCLC and suggested its potential as a tumor marker and prognostic indicator.展开更多
Alzheimer’s Disease (AD) is a chronic and progressive neurodegenerative disease. Flotillin-1 is a marker protein of lipid raft in nervous tissue, which is significantly increased in AD. To investigate the changes of ...Alzheimer’s Disease (AD) is a chronic and progressive neurodegenerative disease. Flotillin-1 is a marker protein of lipid raft in nervous tissue, which is significantly increased in AD. To investigate the changes of flotillin-1 expression in the brains of APP/PS1 double transgenic mice treated with curcumin, thirty six-month-old APP/PS1 double transgenic mice were randomly divided into model group (MOD), low-dose curcumin group (LCUR) and high-dose curcumin group (HCUR). LCUR group mice and HCUR group mice were fed with curcumin (0.16 g.kg-1 and 1.0 g.kg-1, respectively) every day for 6 months. Western blot and real-time PCR were used to detect the expression of flotillin-1 in brain. Results showed that compared with MOD group, the expression of flotillin-1 protein (P P < 0.01) in brains of HCUR group were statistically decreased. Thus, high-dose curcumin may play a neuroprotective role in AD through downregulating the expression of flotillin-1 in APP/PS1 double transgenic mice.展开更多
膜蛋白尼曼-匹克C1型类似蛋白1(Niemann-Pick C1 Like 1,NPC1L1)是介导肝脏和小肠细胞从胆汁或食物中吸收胆固醇的关键蛋白质。本文综述了NPC1L1蛋白的结构、功能及其介导肝肠细胞吸收外源胆固醇的分子机制。NPC1L1蛋白与脂筏蛋白Flotil...膜蛋白尼曼-匹克C1型类似蛋白1(Niemann-Pick C1 Like 1,NPC1L1)是介导肝脏和小肠细胞从胆汁或食物中吸收胆固醇的关键蛋白质。本文综述了NPC1L1蛋白的结构、功能及其介导肝肠细胞吸收外源胆固醇的分子机制。NPC1L1蛋白与脂筏蛋白Flotillin-1或Flotillin-2结合,在细胞质膜上形成富含胆固醇的膜微结构域,通过clathrin/AP2介导的囊泡内吞机制,将该NPC1L1-Flotillin-Cholesterol膜微结构域内吞运输至细胞内的内吞循环体上;内吞循环体上的胆固醇浓度下降后,NPC1L1-Flotillin复合物则由Cdc42和Myosin Vb.Rab11a.Rab11-FIP2蛋白运输至质膜,以执行下一轮的胆固醇吸收功能。NPC1L1蛋白的N端结构域可特异性结合胆固醇,是NPC1L1-Flotillin-Cholesterol膜微结构域形成所必需的,同时决定了胆固醇吸收的特异性。人群中NPC1L1基因的多态性与胆固醇吸收异常相关。本文还对未来的研究方向进行了探讨。展开更多
基金the National Natural Science Foundation of China (Grant No. 81472661, 81490753, 81230047, 81672743, 81772550) Postdoctoral Science Foundation Program of Chinese Academy of Medical Science & Peking Medical College
文摘Objective:Small cell lung carcinoma(SCLC)is considered one of the most aggressive types of lung cancer due to its rapid growth and early metastasis.No tumor markers or therapeutic targets have been demonstrated to be specific or effective in SCLC to date.This study aims to evaluate the potential of Flotillin1(Flot1)as a target of SCLC treatment.Methods:Flot1 expression level in the tissue of SCLC and other tissue of lung disease was detected using immunohistochemical staining.Transwell and Matrigel assays were employed to examine migration and invasion of cancer cells.Flow cytometry and xCELLigence system were used to evaluate cell apoptosis and cell viability,respectively.Expression levels of Flot1,epithelialmesenchymal transition(EMT)marker E-cadherin,vimentin,cyclinD1,TGF-β-Smad2/3,and p-AKT were examined using Western blot.Furthermore,xenograft tumor in nude mice was used to evaluate the growth and metastasis of NCI-H446 cells in vivo.Results:Our results demonstrated that Flot1 is highly expressed in SCLC samples and that its expression correlates strongly with clinical stage,distant metastasis,and poor survival.The knockdown of Flot1 decreased the growth,migration,and invasiveness of SCLC cells and reversed EMT phenotype in vitro and in vivo,while enhanced Flot1 expression exhibited the opposite behavior.Gene expression profile analysis demonstrated that Flot1-regulated genes frequently mapped to the AKT and TGF-β-Smad2/3pathways.Our results further revealed that Flot1 affected the progression of SCLC via regulation of EMT progression.Conclusions:These findings indicated an oncogenic role of Flot1 via promoting EMT in SCLC and suggested its potential as a tumor marker and prognostic indicator.
文摘Alzheimer’s Disease (AD) is a chronic and progressive neurodegenerative disease. Flotillin-1 is a marker protein of lipid raft in nervous tissue, which is significantly increased in AD. To investigate the changes of flotillin-1 expression in the brains of APP/PS1 double transgenic mice treated with curcumin, thirty six-month-old APP/PS1 double transgenic mice were randomly divided into model group (MOD), low-dose curcumin group (LCUR) and high-dose curcumin group (HCUR). LCUR group mice and HCUR group mice were fed with curcumin (0.16 g.kg-1 and 1.0 g.kg-1, respectively) every day for 6 months. Western blot and real-time PCR were used to detect the expression of flotillin-1 in brain. Results showed that compared with MOD group, the expression of flotillin-1 protein (P P < 0.01) in brains of HCUR group were statistically decreased. Thus, high-dose curcumin may play a neuroprotective role in AD through downregulating the expression of flotillin-1 in APP/PS1 double transgenic mice.
文摘膜蛋白尼曼-匹克C1型类似蛋白1(Niemann-Pick C1 Like 1,NPC1L1)是介导肝脏和小肠细胞从胆汁或食物中吸收胆固醇的关键蛋白质。本文综述了NPC1L1蛋白的结构、功能及其介导肝肠细胞吸收外源胆固醇的分子机制。NPC1L1蛋白与脂筏蛋白Flotillin-1或Flotillin-2结合,在细胞质膜上形成富含胆固醇的膜微结构域,通过clathrin/AP2介导的囊泡内吞机制,将该NPC1L1-Flotillin-Cholesterol膜微结构域内吞运输至细胞内的内吞循环体上;内吞循环体上的胆固醇浓度下降后,NPC1L1-Flotillin复合物则由Cdc42和Myosin Vb.Rab11a.Rab11-FIP2蛋白运输至质膜,以执行下一轮的胆固醇吸收功能。NPC1L1蛋白的N端结构域可特异性结合胆固醇,是NPC1L1-Flotillin-Cholesterol膜微结构域形成所必需的,同时决定了胆固醇吸收的特异性。人群中NPC1L1基因的多态性与胆固醇吸收异常相关。本文还对未来的研究方向进行了探讨。
